Literature DB >> 28936637

Significant prognostic factors affecting treatment outcomes of salivary gland carcinoma: a multicenter retrospective analysis.

Shin-Ichi Yamada1, Hiroshi Kurita2, Takahiro Kamata1, Tadaaki Kirita3, Michihiro Ueda4, Tetsuro Yamashita4, Yoshihide Ota5, Mitsunobu Otsuru5, Nobuhiro Yamakawa3, Masaya Okura6, Tomonao Aikawa6, Masahiro Umeda7.   

Abstract

The purpose of this study was to investigate the prognostic factor in salivary gland carcinoma patients. Clinical and pathological data of 211 consecutive patients who treated with curative intent were analyzed. The overall survival (OS) rate, local control rate, and distant metastasis rate were calculated. To examine a prognostic factor in salivary gland carcinoma patients, a multivariate analysis was performed. The 5-year-OS rate was 84.0%, and 10-year was 69.2%. The 5-year-local control rate was 84.6%, and 10-year was 70.1%. The 5-year-distant metastasis rate was 16.9%, and 10-year was 21.1%. In a multivariate analysis, the OS rate was affected by pN(+), high-grade malignancy, and primary tumor size. The local control was affected by the primary tumor size, high-grade malignancy, and the status of the surgical margin. The primary tumor size and pN(+) were associated with the distant metastasis. The results of this study suggested that pN(+), malignancy grade, primary tumor size, and the margin status might affect the prognosis of salivary gland carcinoma patients. Postoperative radiotherapy and adjuvant chemotherapy were suggested the possibility of contribution to the good prognosis of salivary gland carcinoma patients.

Entities:  

Keywords:  Multivariate analysis; Prognostic factor; Salivary gland carcinoma; Survival analysis; Treatment outcome

Mesh:

Year:  2017        PMID: 28936637     DOI: 10.1007/s10266-017-0318-1

Source DB:  PubMed          Journal:  Odontology        ISSN: 1618-1247            Impact factor:   2.634


  20 in total

1.  Prognostic significance of Ki-67 in salivary gland carcinomas.

Authors:  Stine Rosenkilde Larsen; Kristine Bjørndal; Christian Godballe; Annelise Krogdahl
Journal:  J Oral Pathol Med       Date:  2012-04-24       Impact factor: 4.253

2.  Malignant salivary gland tumours in Sweden 1960-1989--an epidemiological study.

Authors:  J Ostman; G Anneroth; H Gustafsson; B Tavelin
Journal:  Oral Oncol       Date:  1997-05       Impact factor: 5.337

3.  Salivary gland cancer in the United States.

Authors:  E C Sun; R Curtis; M Melbye; J J Goedert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

4.  Malignant epithelial salivary gland tumors in northern Finland: incidence and clinical characteristics.

Authors:  Petri Koivunen; Leena Suutala; Ingrid Schorsch; Kalevi Jokinen; Olli-Pekka Alho
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-03       Impact factor: 2.503

5.  Incidence rates of salivary gland tumors: results from a population-based study.

Authors:  J A Pinkston; P Cole
Journal:  Otolaryngol Head Neck Surg       Date:  1999-06       Impact factor: 3.497

6.  Failure patterns and factors affecting prognosis of salivary gland carcinoma: retrospective study.

Authors:  P M Teo; A T Chan; W Y Lee; S F Leung; E S Chan; C O Mok
Journal:  Hong Kong Med J       Date:  2000-03       Impact factor: 2.227

7.  A prognostic index for predicting lymph node metastasis in minor salivary gland cancer.

Authors:  Shane Lloyd; James B Yu; Douglas A Ross; Lynn D Wilson; Roy H Decker
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

Review 8.  Prognostic factors in malignant tumours of the salivary glands.

Authors:  Paul M Speight; A William Barrett
Journal:  Br J Oral Maxillofac Surg       Date:  2009-05-05       Impact factor: 1.651

9.  Clinico-pathological and treatment-related factors influencing survival in parotid cancer.

Authors:  A G Renehan; E N Gleave; N J Slevin; M McGurk
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

10.  Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma.

Authors:  Yukio Watabe; Taisuke Mori; Seiichi Yoshimoto; Takeshi Nomura; Takahiko Shibahara; Tesshi Yamada; Kazufumi Honda
Journal:  Cancer Med       Date:  2014-02-27       Impact factor: 4.452

View more
  2 in total

1.  Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy.

Authors:  Claudia Scherl; Marlen Haderlein; Abbas Agaimy; Konstantinos Mantsopoulos; Michael Koch; Maximilian Traxdorf; Rainer Fietkau; Philipp Grundtner; Heinrich Iro
Journal:  Strahlenther Onkol       Date:  2019-07-26       Impact factor: 3.621

2.  Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period.

Authors:  Michał Żurek; Kamil Jasak; Karolina Jaros; Piotr Daniel; Kazimierz Niemczyk; Anna Rzepakowska
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.